Evidence map›Paper›PMID 40378378›Full record

ArticleNeurology2025

Automated Whole-Brain Focal Cortical Dysplasia Detection Using MR Fingerprinting With Deep Learning.

Zheng Ding, Spencer Morris, Siyuan Hu, Ting-Yu Su, Joon Yul Choi, Ingmar Blümcke, Xiaofeng Wang, Ken Sakaie, Hiroatsu Murakami, Andreas V Alexopoulos and 4 more

Abstract read
In one paragraph

Article in Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. AI in epilepsy neuroimaging.Current opinion in neurology · 2026
    Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Zheng DingEpilepsy Center, Neurological Institute, Cleveland Clinic, OH.
Spencer MorrisEpilepsy Center, Neurological Institute, Cleveland Clinic, OH.
Siyuan HuDepartment of Biomedical Engineering, Case Western Reserve University, OH.
Ting-Yu SuEpilepsy Center, Neurological Institute, Cleveland Clinic, OH.
Joon Yul ChoiEpilepsy Center, Neurological Institute, Cleveland Clinic, OH.
Ingmar BlümckeEpilepsy Center, Neurological Institute, Cleveland Clinic, OH.ORCID 0000-0001-8676-0788
Xiaofeng WangQuantitative Health Science, Cleveland Clinic, OH.
Ken SakaieImaging Institute, Cleveland Clinic, OH; and.
Hiroatsu MurakamiEpilepsy Center, Neurological Institute, Cleveland Clinic, OH.
Andreas V AlexopoulosEpilepsy Center, Neurological Institute, Cleveland Clinic, OH.ORCID 0000-0003-0214-3286
Stephen E JonesImaging Institute, Cleveland Clinic, OH; and.ORCID 0000-0001-6511-9078
Imad M NajmEpilepsy Center, Neurological Institute, Cleveland Clinic, OH.
Dan MaDepartments of Neurosurgery and Biomedical Engineering, Duke University, Durham, NC.
Zhong Irene Wang

Funding

MR Fingerprinting for EpilepsyR01NS109439 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI Dan Ma, Zhong Irene Wang · 2019 to 2026
$4.2M
Comprehensive MR Fingerprinting for Infants and Young Children at Risk for Developmental Delays.R01HD112923 · NICHD · DUKE UNIVERSITY · PI Dan Ma, DEANNE E WILSON-COSTELLO · 2024 to 2026
$1.7M
NICHD NIH HHS R01 HD112923NINDS NIH HHS R01 NS109439
6 · The paper itself

Abstract

BACKGROUND AND

objectivesFocal cortical dysplasia (FCD) is a common pathology for pharmacoresistant focal epilepsy, yet detection of FCD on clinical MRI is challenging. Magnetic resonance fingerprinting (MRF) is a novel quantitative imaging technique providing fast and reliable tissue property measurements. The aim of this study was to develop an MRF-based deep-learning (DL) framework for whole-brain FCD detection.

methodsWe included patients with pharmacoresistant focal epilepsy and pathologically/radiologically diagnosed FCD, as well as age-matched and sex-matched healthy controls (HCs). All participants underwent 3D whole-brain MRF and clinical MRI scans. T1, T2, gray matter (GM), and white matter (WM) tissue fraction maps were reconstructed from a dictionary-matching algorithm based on the MRF acquisition. A 3D ROI was manually created for each lesion. All MRF maps and lesion labels were registered to the Montreal Neurological Institute space. Mean and SD T1 and T2 maps were calculated voxel-wise across using HC data. T1 and T2

resultsWe included 40 patients with FCD (mean age 28.1 years, 47.5% female; 11 with FCD IIa, 14 with IIb, 12 with mMCD, 3 with MOGHE) and 67 HCs. The DL model with optimal performance used all MRF-based inputs, including MRF-synthesized T1w, T1z, and T2z maps; tissue fraction maps; and morphometric maps. The patient-level sensitivity was 80% with an average of 1.7 false positives (FPs) per patient. Sensitivity was consistent across subtypes, lobar locations, and lesional/nonlesional clinical MRI. Models using clinical images showed lower sensitivity and higher FPs. The MRF-DL model also outperformed the established MAP18 pipeline in sensitivity, FPs, and lesion label overlap. DISCUSSION: The MRF-DL framework demonstrated efficacy for whole-brain FCD detection. Multiparametric MRF features from a single scan offer promising inputs for developing a deep-learning tool capable of detecting subtle epileptic lesions.

Indexed as

BrainDeep LearningMagnetic Resonance ImagingMalformations of Cortical DevelopmentAdolescentAdultDrug Resistant EpilepsyFemaleFocal Cortical DysplasiaGray MatterHumansMaleMiddle AgedWhite MatterYoung Adult

Identifiers

PMID40378378
PMCPMC12089660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.